Hepatitis B virus coinfection in patients treated for chronic hepatitis C: clinical characteristics, risk of reactivation with long-term follow-up, and effectiveness of antiviral therapy.  Zarębska-Michaluk D, Brzdęk M, Rzymski P, Dobrowolsk...

Effect of integrated hepatitis C virus treatment on psychological distress in people with substance use disorders.  Aas CF, Vold JH, Chalabianloo F, Løberg EM, Lim AG, Vickerman P, Johansson KA, Fadnes LT.  Sci Rep. 2024 Jan 8;14(1):81...

Has the HCV cascade of care changed among people who inject drugs in England since the introduction of direct-acting antivirals?  Gliddon HD, Ward Z, Heinsbroek E, Croxford S, Edmundson C, Hope VD, Simmons R, Mitchell H, Hickman M, Vickerman...

Initiation of oral hepatitis C virus treatment: Which barriers are pertinent for ambulatory individuals with a history of illicit substance use? A qualitative interview study.  Barbati S, Strasser J, Allemann SS, Arnet I.  Health Sci R...

High prevalence of hepatitis B virus susceptibility among persons undergoing community-based hepatitis C virus treatment.  Campusano C, Kanner R, McDonell C, Morris M, Duarte M, Price JC.  Harm Reduct J. 2024 Jan 29;21(1):25. doi: 10.1...

Eliminating Hepatitis C in Europe: Report on Policy Implementation for People Who Inject Drugs We are excited to launch Eliminating Hepatitis C in Europe: Report on Policy Implementation for People Who Inject Drugs! The publication is part of C-E...